{"transactions":[{"id":695328,"issuer":{"id":4898,"kind":"organization","name":"Obsidian Therapeutics, Inc."},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T20:05:22.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":37653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":37653,"derivative":{"exercise_price":12,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":37653},"source":{"system":"sec-edgar","filing":"0001193125-26-335045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559231/000119312526335045/ownership.xml","form_type":"4"}},{"id":744663,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:43:39.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264290/ownership.xml","form_type":"4"}},{"id":1119662,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:30:09.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":38.57,"expiration_date":"2035-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-25-083268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025083268/ownership.xml","form_type":"4"}},{"id":1496686,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:15:06.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":54.06,"expiration_date":"2034-05-30","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-24-067326","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024067326/ownership.xml","form_type":"4"}},{"id":1860523,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:33:11.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":62.59,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-23-035974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123035974/doc4.xml","form_type":"4"}},{"id":2235955,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T21:37:48.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2022 with respect to 24,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments."}],"balance_after":24000,"derivative":{"exercise_price":71.7,"expiration_date":"2032-06-09","underlying":"Common Shares","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-036037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122036037/doc4.xml","form_type":"4"}},{"id":2915299,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T22:01:12.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":250000,"derivative":{"exercise_price":46.26,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-001577","document":"tm211898-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465921001577/tm211898-3_4seq1.xml","form_type":"4"}},{"id":3126826,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T23:19:58.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":1894,"price":33.12,"value":62729.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."}],"balance_after":298786,"source":{"system":"sec-edgar","filing":"0001104659-20-069097","document":"tm2021603d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920069097/tm2021603d1_4.xml","form_type":"4"}},{"id":3163533,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-05T01:01:21.000Z","date":"2020-05-01","kind":"tax_withholding","acquired":false,"shares":1894,"price":32,"value":60608.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested RSUs."}],"balance_after":300680,"source":{"system":"sec-edgar","filing":"0001104659-20-056429","document":"tm2018523-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920056429/tm2018523-1_4.xml","form_type":"4"}},{"id":3182977,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-03T20:30:17.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":1494,"price":27.94,"value":41742.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested RSUs."}],"balance_after":302574,"source":{"system":"sec-edgar","filing":"0001104659-20-043125","document":"tm2014835d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920043125/tm2014835d1_4.xml","form_type":"4"}},{"id":3227201,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-04T22:00:38.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":1321,"price":35.99,"value":47542.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested RSUs."}],"balance_after":304068,"source":{"system":"sec-edgar","filing":"0001104659-20-029218","document":"tm2011589d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920029218/tm2011589d1_4.xml","form_type":"4"}},{"id":3288513,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T21:31:43.000Z","date":"2020-02-03","kind":"tax_withholding","acquired":false,"shares":1302,"price":22.54,"value":29347.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested RSUs."}],"balance_after":305389,"source":{"system":"sec-edgar","filing":"0001104659-20-011256","document":"tm206837-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920011256/tm206837-1_4.xml","form_type":"4"}},{"id":3316241,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-08T02:00:47.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 500,000 shares shall vest on the one-year anniversary of January 3, 2020; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of January 3, 2020."}],"balance_after":500000,"derivative":{"exercise_price":25.54,"expiration_date":"2030-01-02","underlying":"Common stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-20-002086","document":"tm201473d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920002086/tm201473d1_4.xml","form_type":"4"}},{"id":3318235,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-07T00:00:23.000Z","date":"2020-01-02","kind":"tax_withholding","acquired":false,"shares":1562,"price":26.68,"value":41674.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested RSUs."}],"balance_after":306691,"source":{"system":"sec-edgar","filing":"0001104659-20-001682","document":"tm201275d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920001682/tm201275d1_4.xml","form_type":"4"}},{"id":3352437,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:28.000Z","date":"2019-12-02","kind":"tax_withholding","acquired":false,"shares":1894,"price":22.66,"value":42918.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":308253,"source":{"system":"sec-edgar","filing":"0001104659-19-070008","document":"tm1924459d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070008/tm1924459d2_4.xml","form_type":"4"}},{"id":3352436,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:28.000Z","date":"2019-11-01","kind":"tax_withholding","acquired":false,"shares":1894,"price":21.97,"value":41611.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":310147,"source":{"system":"sec-edgar","filing":"0001104659-19-070008","document":"tm1924459d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070008/tm1924459d2_4.xml","form_type":"4"}},{"id":3352468,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-10-01","kind":"tax_withholding","acquired":false,"shares":1894,"price":18.21,"value":34489.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":312041,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352467,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-09-03","kind":"tax_withholding","acquired":false,"shares":1610,"price":20.27,"value":32634.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":313935,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352466,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":25.17,"value":33249.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":315545,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352465,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-07-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":24.62,"value":32523.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":316866,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352464,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-06-03","kind":"tax_withholding","acquired":false,"shares":1321,"price":18.04,"value":23830.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":318187,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352463,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-05-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":11.14,"value":14715.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":319508,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352462,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":9.78,"value":12919.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":320829,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352461,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":1298,"price":10.77,"value":13979.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":322150,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352460,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-02-01","kind":"tax_withholding","acquired":false,"shares":1562,"price":9.26,"value":14464.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":323448,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352459,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2019-01-02","kind":"tax_withholding","acquired":false,"shares":1562,"price":9.45,"value":14760.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":325010,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352458,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-12-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":10.44,"value":13791.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":326572,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352457,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-11-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":9.62,"value":12708.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":327893,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352456,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-10-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":11.12,"value":14689.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":329214,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352455,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-09-04","kind":"tax_withholding","acquired":false,"shares":1321,"price":17.1,"value":22589.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":330535,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352454,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-08-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":13.7,"value":18097.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":331856,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352453,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-07-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":12.8,"value":16908.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":333177,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352452,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-06-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":14.55,"value":19220.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":334498,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352451,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-05-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":14.6,"value":19286.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":335819,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352450,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":16.9,"value":22324.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":337140,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352449,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":1321,"price":18.15,"value":23976.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":338461,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352448,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-02-01","kind":"tax_withholding","acquired":false,"shares":1525,"price":16.5,"value":25162.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":339782,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352447,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2018-01-01","kind":"tax_withholding","acquired":false,"shares":1562,"price":8,"value":12496.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":341307,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352446,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-12-01","kind":"tax_withholding","acquired":false,"shares":1994,"price":8.8,"value":17547.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":342869,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352445,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-11-01","kind":"tax_withholding","acquired":false,"shares":1994,"price":7.15,"value":14257.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":344863,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352444,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-10-01","kind":"tax_withholding","acquired":false,"shares":1993,"price":7.75,"value":15445.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":346857,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352443,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-09-01","kind":"tax_withholding","acquired":false,"shares":1994,"price":6,"value":11964.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":348850,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352442,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-08-01","kind":"tax_withholding","acquired":false,"shares":1993,"price":5.7,"value":11360.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":350844,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352441,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-07-01","kind":"tax_withholding","acquired":false,"shares":1994,"price":7.35,"value":14655.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":352837,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352440,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-06-01","kind":"tax_withholding","acquired":false,"shares":143496,"price":5.45,"value":782053.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":354831,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3352439,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-05T02:01:17.000Z","date":"2017-04-03","kind":"tax_withholding","acquired":false,"shares":51673,"price":7.15,"value":369461.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exempt transaction pursuant to Section 16(b) and the rules thereunder. All of the shares reported as disposed of in this Form 4 were automatically withheld by the Issuer in accordance with the terms of the grant of the Restricted Stock Units (\"RSUs\") dated June 1, 2016, to satisfy federal and state tax withholding and payment obligations resulting from the vesting and settlement of RSUs. The Reporting Person did not receive or sell any of the shares reported on this Form 4 item; these shares were withheld and subsequently canceled by the Issuer in accordance with the foregoing. The grant of the RSUs was previously reported in Table I of the Reporting Person's initial Form 4 reporting the acquisition of common stock pursuant to the June 1, 2016 grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported include unvested Restricted Stock Units (\"RSUs\")."}],"balance_after":498327,"source":{"system":"sec-edgar","filing":"0001104659-19-070006","document":"tm1924459d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465919070006/tm1924459d1_4.xml","form_type":"4"}},{"id":3608252,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-06T22:00:40.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 400,000 shares shall vest on the one-year anniversary of March 4, 2019; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of March 4, 2019."}],"balance_after":400000,"derivative":{"exercise_price":11.26,"expiration_date":"2019-03-04","underlying":"Common stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001144204-19-012581","document":"tv515609_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000114420419012581/tv515609_4.xml","form_type":"4"}},{"id":4066026,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-13T01:18:53.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of 166,672 shares shall vest on February 9, 2019; and (ii) the remaining stock options shall vest as to 41,666 shares in eight quarterly installments over the two years following February 9, 2019."}],"balance_after":500000,"derivative":{"exercise_price":16.8,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001250853-18-000038","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000125085318000038/primary_doc.xml","form_type":"4"}}]}